FusePaq Synapryn and Insulin glargine and lixisenatide
Determining the interaction of FusePaq Synapryn and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tramadol
Brand name: ConZip, Ultram, Ultram ER, Rybix ODT, Ryzolt
Synonyms: Tramadol, TraMADol
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- FusePaq Synapryn-Insulin glargine and lixisenatide Subcutaneous
- FusePaq Synapryn-Insulin glargine, recombinant Subcutaneous
- FusePaq Synapryn-Insulin glulisine
- FusePaq Synapryn-Insulin Glulisine (Cartridges and Pens)
- FusePaq Synapryn-Insulin Glulisine (Vials)
- FusePaq Synapryn-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-FusePaq Tabradol
- Insulin glargine and lixisenatide-Fusilev
- Insulin glargine and lixisenatide-Fusion
- Insulin glargine and lixisenatide-Fusion Plus (Vitamin B Complex and Iron Combinations Tablets and Capsules)
- Insulin glargine and lixisenatide-Fusion Plus (Vitamins (Multiple/Oral))
- Insulin glargine and lixisenatide-Fuzeon